197 evolution "https:" "https:" "https:" "UCL" "UCL" "UCL" positions at Cardiff University in United Kingdom
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Advert Development Officer (Leadership) & CASE Intern Cardiff University’s Development and Alumni Relations team are recruiting for a one-year, fixed term full-time CASE Graduate Trainee to join our
-
- Development Officer (Leadership) Cardiff University’s Development and Alumni Relations team are recruiting for an open-ended, full-time Development Officer (Leadership Giving) to join their Fundraising Team
-
to many high-profile ground, balloon and space-based experiments. Our group is now making a major contribution to the LiteBIRD satellite, with the collaborative development of arrays of dual-colour, dual
-
Advert Senior Professional Specialist in Technical Innovation and Development Centre for Trials Research (CTR) College of Biomedical & Life Sciences The Centre for Trials Research at Cardiff
-
Cognitive Health in Psychotic Disorders”, and the post-holder will be part of a larger team based in the Universities of Bath, Cambridge, Oxford, UCL and Jena (Germany). In this role, you will
-
universities in the world and the top 20 in the UK. Opportunity The Data Architect will lead design and development of the common data platform and provide oversight during implementation to ensure
-
national profile. To undergo personal and professional development that is appropriate to and which will enhance performance. To participate in Centre and School administration and activities to promote
-
and contribute to the development of independent and original ideas as appropriate To provide support in research activities for undergraduate courses and research programmes and provide guidance
-
advisory group of senior leaders and policy makers, and also has set up advisory panels of practitioners and people with lived experience of receiving social care services. The development of CARE is
-
neuroinflammation and neurodegeneration, and the development and testing of novel brain-penetrant complement-blocking drugs in vitro and in vivo for their ability to inhibit the complement system, their penetrance